DEVELOPING ADMINISTERING DISEASE MANAGEMENT

Brand	Owner	Address	Description
SMARTCARE	New Hampshire-Vermont Health Service	Two Pillsbury Street Concord NH 03306	developing and administering disease management programs;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Kidney disease is diagnosed by measuring urinary catalytic iron in humans. Progressive kidney disease is treated by administering an iron chelator to humans. In particular, the progression of kidney disease essentially can be halted and the severity of kidney disease can be reduced by the administration of iron chelators to humans afflicted with a progressive kidney disease. The methods include measuring catalytic iron content in urine in a human afflicted with a progressive kidney disease and administering an iron chelator to the human. The method can include measuring total urinary protein content, blood urea nitrogen or creatinine in a blood sample before, during or after the administration of an iron chelator.